Baseline eGFR, albuminuria and renal outcomes in patients with SGLT2 inhibitor treatment: an updated meta-analysis
Yunke Ma(Peking University), Linong Ji(Peking University), Suiyuan Hu(Peking University), Wenjia Yang(Peking University), Chu Lin(Peking University), Fang Lv(Liaoning Normal University), Xingyun Zhu(Peking University), Xiaoling Cai(Peking University)
Cited by 12
Related Papers
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies
|Journal of Nanoparticle Research|2014|128
CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2022|115